B-cells aggravate autoimmune diseases

Antibody producers regulate the immune response using a recently discovered mechanism

2014-03-05

(Press-News.org) This news release is available in German.

Scientists in Freiburg may have discovered a fundamental aggravating factor in autoimmune diseases. If B-lymphocytes lack the protein PTP1B, the cells will become hyperactive for stimulatory signals and can thus promote an autoimmune attack. This study offers an additional explanation to how B-cells regulate an immune response.

In Germany, approximately 800,000 people suffer from rheumatoid arthritis. In this progressive disease, a person's own immune system attacks and destroys connective tissue. However, the most important factors governing the progress of the disease are still unknown. Now, scientists working with Michael Reth and David Medgyesi from the Max Planck Institute of Immunobiology and Epigenetics have identified a factor that may play a significant role. Using genetic engineering, they deactivated the PTP1B protein in B-cells in the immune systems of mice. The B-cells then became much more responsive to activating signals and, in turn, served to reactivate the other cells. PTP1B could therefore have a monitoring function in the B-cell-mediated immune response. Until now, B-cells were mainly known for producing antibodies after coming into contact with pathogens. Only recently is more and more accepted by researchers that B-lymphocytes possess important regulatory function in the immune system. The current study now provides a new detail of this mechanism.

A clinical investigation showed that B-cells in patients suffering from rheumatoid arthritis also produce unusually low amounts of the studied protein. In the patients' other cell types, and in healthy subjects, this was not the case. "This suggests that the protein plays a significant role in the development or the aggravated course of rheumatoid arthritis", says principal investigator Michael Reth. Reth is head of the Molecular Immunology department at the Max Planck Institute of Immunobiology and Epigenetics, as well as scientific director of the Centre for Biological Signalling Studies (BIOSS), a German Cluster of Excellence at the University of Freiburg.

In cases of rheumatoid arthritis in which conventional treatments are ineffective, patients can be treated with the drug Rituximab. The drug destroys all B-cells in the body and will thus at least halt the progress of the disease. "The B-cells produced after the Rituximab therapy possess similar amount of the PTP1B protein as cells in healthy people. This may contribute to the less severe autoimmune reaction", explains first author David Medgyesi. Long-term studies are required to determine whether these newly produced cells will lose the protein over time.

By the end of the 1990s, the laboratory headed by Michael Reth had already developed mice with B-cells in which specific genes could be knocked out using Cre-lox technology. In the meantime, this mouse strain is being used very successfully in over 200 laboratories around the world to study the functioning of the immune system.

INFORMATION: Original work: Medgyesi D, Hobeika E, Biesen R, Kollert F, Taddeo A, Voll RE, Hiepe F, and Reth M. (2014). The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.
Journal of Experimental Medicine, doi: 10.1084/jem.20131196

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

With flip of wrist, interventional radiologists treat uterine fibroids

2014-03-05

FAIRFAX, Va.—Interventional radiologists have devised a new way to access a woman's fibroids—by flipping her wrist and treating via an arm not groin artery—to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)—with no overnight stay, according to a March article in the Society of Interventional Radiology's flagship publication, the Journal of Vascular and Interventional Radiology. "Improving ...

When disaster strikes: Safeguarding networks

2014-03-05

WASHINGTON, March 5, 2014–Disasters both natural and human-caused can damage or destroy data and communications networks. Several presentations at the 2014 OFC Conference and Exposition, being held March 9-13 in San Francisco, Calif., USA will present new information on strategies that can mitigate the impacts of these disasters. New Algorithm Finds Safe Refuge for Cloud Data Much of our computing these days, from browsing websites and watching online videos to checking email and following social networks, relies on the cloud. The cloud lives in data centers – massive ...

A wristband for a different kind of cause -- environmental health

2014-03-05

From "Livestrong" to "Purple Paws," trendy wristbands have come to represent causes from cancer to ending cruelty to animals. Add a new wristband of a different sort: one that could close the loop on determining the potential disease risks of exposure to substances like pesticides. Scientists reported the development in the ACS journal Environmental Science & Technology. Kim Anderson and colleagues note that people breathe, touch and ingest a mix of many substances at low levels every day. But figuring out if natural and synthetic compounds can lead to disease is difficult. ...

Hop leaves -- discarded in beer brewing -- have substances that could fight dental diseases

2014-03-05

Beer drinkers know that hops are what gives the drink its bitterness and aroma. Recently, scientists reported that the part of hops that isn't used for making beer contains healthful antioxidants and could be used to battle cavities and gum disease. In a new study in ACS' Journal of Agricultural and Food Chemistry, they say that they've identified some of the substances that could be responsible for these healthful effects. Yoshihisa Tanaka and colleagues note that their earlier research found that antioxidant polyphenols, contained in the hop leaves (called bracts) ...

Adolescent relationship violence has mental health implications for victims, perpetrators

2014-03-05

WASHINGTON, DC, March 5, 2014 — Described by the Centers for Disease Control and Prevention as "physical, sexual, or psychological harm by a current or former partner or spouse," intimate partner violence (IPV) is a serious public health issue affecting millions of people in the United States. New research from sociologists at Bowling Green State University (BGSU) shows that adolescents and young adults who perpetrate or fall victim to IPV are more likely to experience an increase in symptoms of depression. Titled, "Intimate Partner Violence and Depressive Symptoms During ...

Pigment or bacteria? Researchers re-examine the idea of 'color' in fossil feathers

2014-03-05

Paleontologists studying fossilized feathers have proposed that the shapes of certain microscopic structures inside the feathers can tell us the color of ancient birds. But new research from North Carolina State University demonstrates that it is not yet possible to tell if these structures – thought to be melanosomes – are what they seem, or if they are merely the remnants of ancient bacteria. Melanosomes are small, pigment-filled sacs located inside the cells of feathers and other pigmented tissues of vertebrates. They contain melanin, which can give feathers colors ...

Rough surface could keep small electronic parts from sticking together

2014-03-05

When a piece of gift-wrapping tape sticks to itself, it's frustrating, but when small parts in a microgear or micromotor stick together, an electronic device may not work well, if at all. Scientists now report in the journal ACS Applied Materials & Interfaces that rough zinc oxide coatings can prevent tiny silicon parts from adhering to each other. The study could accelerate the development of even more advanced, high-performance electronics and small sensors. Xinchun Lu and colleagues explain that adhesion is a big concern when designing very small silicon-based machines ...

Synthetic spider silk strong enough for a superhero

2014-03-05

Spider silk of fantastical, superhero strength is finally speeding toward commercial reality — at least a synthetic version of it is. The material, which is five times stronger than steel, could be used in products from bulletproof vests to medical implants, according to an article in Chemical & Engineering News (C&EN). C&EN is the weekly news magazine of the American Chemical Society. Alex Scott, a senior editor at C&EN, notes that spider silk's impressive strength has been studied for years, and scientists have been trying to make a synthetic version of the super-strong ...

Lung transplantation: A treatment option in end-stage lung disease

2014-03-05

In the past five years, the number of lung transplantations carried out has increased by about 20%. In the end stage of various lung diseases, transplantation is the last remaining option for treatment, and it can both prolong life and improve its quality. Marc Hartert and colleagues have studied how patients do after a lung transplant, and their review appears in the current edition of the Deutsches Ärzteblatt International (Dtsch Arztebl Int 2014; 111(7): 107–16). What they found is that deaths in the 90 days after an operation for lung transplantation have gone down ...

Experiential avoidance increases PTSD risk following child maltreatment

2014-03-05

Child abuse is a reliable predictor of post-traumatic stress disorder, but not all maltreated children suffer from it, according to Chad Shenk, assistant professor of human development and family studies, Penn State, who examined why some maltreated children develop PTSD and some do not. Shenk and his research team found that adolescent girls who experienced maltreatment in the past year and were willing to talk about their painful experiences and their thoughts and emotions, were less likely to have PTSD symptoms one year later. Those who tried to avoid painful thoughts ...

CUNY Graduate Center and its academic partners awarded more than $1M by Google.org to advance statewide AI education through the Empire AI consortium

Mount Sinai Health system receives $8.5 million NIH grant renewal to advance research on long-term outcomes in children with congenital heart disease

Korea University researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer

NTU Singapore-led team captures first-ever ‘twitch’ of the eye’s night-vision cells as they detect light, paving the way for earlier detection of blindness-causing diseases

B-cells aggravate autoimmune diseases

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: